Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


India’s Commerce Ministry Moves To Block Generic Approval Proposal

This article was originally published in PharmAsia News

Executive Summary

One Indian Cabinet office has intervened to block a proposal by the country's drug authority to withhold market approval for generics of patented drugs. The commerce ministry moved to block the proposal on grounds the patent agency should not be involved in the drug-approval process. The Drug Controller General of India had proposed to involve the patent office in the denial effort. The commerce ministry says approvals should be based on whether a drug should be approved for the market and that the issue of a patent should not be a criterion in that decision. (Click here for more



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts